In other organ systems, selective loss of Capns1 in the pulmonary artery smooth muscle cells displays a protective effect in pulmonary hypertension and lung damage (22), suggesting that inhibiting this pathway may provide an avenue for novel therapeutics. This evidence concerns the gene CAPNS1 and pulmonary arterial hypertension.